Home

Jafron Biomedical Co., Ltd. (300529)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Jafron Biomedical Co., Ltd. (300529)

Go deeper and ask any question about 300529

Company Performance

Current Price

as of Sep 13, 2024

$3.49

P/E Ratio

26.98

Market Cap

$2.78B

Description

Jafron Biomedical Co., Ltd. engages in the research, development, production, and sale of hemoperfusion products. Its products include HA series hemoperfusion cartridge, BS bilirubin adsorption column, DNA immunoadsorption column, hemoperfusion machine, blood purification machine and other products. The company was founded on December 19, 1989 and is headquartered in Zhuhai, China.

Metrics

Overview

  • HQZhuhai, GD
  • SectorHealth Technology
  • IndustryMedical Specialties
  • Ticker300529
  • Price$3.492847-1.14%

Trading Information

  • Market Cap$2.78B
  • Float75.03%
  • Average Daily Volume (1m)3,695,597
  • Average Daily Volume (3m)5,108,332
  • EPS$0.92

Company

  • Revenue$2.37B
  • Rev Growth (1yr)70.90%
  • Net Income$267.74M
  • Gross Margin79.63%
  • EBITDA Margin46.87%
  • EBITDA$346.36M
  • EV$21.11B
  • EV/Revenue8.92
  • P/E26.98
  • P/S8.49
Documents